Elocon 0.1% ointment

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Mometasone furoate

Available from:

Organon Pharma (UK) Ltd

ATC code:

D07AC13

INN (International Name):

Mometasone furoate

Dosage:

1mg/1gram

Pharmaceutical form:

Cutaneous ointment

Administration route:

Cutaneous

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 13040000; GTIN: 5012376019727 5012376022635

Patient Information leaflet

_S1493 LEAFLET Elocon 20191011 _
PACKAGE LEAFLET: INFORMATION FOR USER
ELOCON
® OINTMENT / MOMETASONE FUROATE 0.1%
OINTMENT
(mometasone furoate)
Your medicine is known as Elocon
®
Ointment / Mometasone
Furoate 0.1% Ointment but will be referred to as Elocon throughout
the following leaflet.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor, pharmacist
or nurse.

This medicine has been prescribed for you only. Do not pass it
on to others. It may harm them, even if their signs of illness are
the same as yours.

If you get any side effects, talk to your doctor, pharmacist or
nurse. This includes any possible side effects not listed in this
leaflet. See Section 4.
WHAT IS IN THIS LEAFLET
1. What Elocon is and what it is used for
2. What you need to know before you use Elocon
3. How to use Elocon
4. Possible side effects
5. How to store Elocon
6. Contents of the pack and other information
1.
WHAT ELOCON IS AND WHAT IT IS USED FOR
Elocon Ointment is one of a group of medicines called topical
corticosteroids. It is classified as a “potent corticosteroid”.
These
medicines are put on the surface of the skin to reduce the redness
and itchiness caused by certain skin problems.
In adults and children, Elocon Ointment is used to reduce redness
and itchiness caused by certain skin problems called psoriasis or
dermatitis.
Psoriasis is a skin disease in which itchy, scaly, pink patches
develop on the elbows, knees, scalp and other parts of the body.
Dermatitis is a condition brought on by the skin reacting to outside
agents e.g. detergents, causing the skin to become red and itchy.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE ELOCON
DO NOT USE ELOCON:
If you have:

an allergy (hypersensitivity) to mometasone furoate or any of
the other ingredients in this medicine (listed in section 6) or to
other similar medicines.

any other skin probl

Summary of Product characteristics

OBJECT 1
ELOCON OINTMENT
Summary of Product Characteristics Updated 31-Oct-2017 | Merck Sharp &
Dohme Limited
1. Name of the medicinal product
Elocon Ointment®
Mometasone Furoate 0.1% w/w Ointment
2. Qualitative and quantitative composition
Mometasone Furoate 0.1% w/w
Propylene glycol stearate 2.0% w/w
For full list of excipients see section 6.1
3. Pharmaceutical form
Ointment
4. Clinical particulars
4.1 Therapeutic indications
Elocon/ Mometasone Furoate 0.1% w/w Ointment is indicated for the
treatment of inflammatory and
pruritic manifestations of psoriasis (excluding widespread plaque
psoriasis) and atopic dermatitis.
4.2 Posology and method of administration
_Adults, including elderly patients and children :_ A thin film of
Elocon/ Mometasone Furoate 0.1% w/w
Ointment should be applied to the affected areas of skin once daily.
Use of topical corticosteroids in children or on the face should be
limited to the least amount compatible
with an effective therapeutic regimen and duration of treatment should
be no more than 5 days.
4.3 Contraindications
Elocon/ Mometasone Furoate 0.1% w/w is contraindicated in facial
rosacea, acne vulgaris, skin atrophy,
perioral dermatitis, perianal and genital pruritis, napkin eruptions,
bacterial (e.g. impetigo, pyodermas),
viral (e.g. herpes simplex, herpes zoster and chickenpox, verrucae
vulgares, condylomata acuminata,
molluscum contagiosum), parasitical and fungal (e.g. candida or
dermatophyte) infections, varicella,
tuberculosis, syphilis or post-vaccine reactions. Elocon/ Mometasone
Furoate 0.1% w/w should not be
used on wounds or skin which is ulcerated. Elocon/ Mometasone Furoate
0.1% w/w should not be used in
patients who are sensitive to mometasone furoate or to other
corticosteroids or to any of the excipients
listed in section 6.1.
4.4 Special warnings and precautions for use
If irritation or sensitisation develop with the use of Elocon/
Mometasone Furoate 0.1% w/w, treatment
should be withdrawn and appropriate therapy instituted.
Should an infection develop, use of a